
Binance lists 5 TradFi perpetuals with 20x leverage, targeting Trump Media, Moderna and chip ETFs. The products carry layered risk from daily-reset funds and 24/7 trading gaps.
Binance Futures launched five USDT-margined TradFi perpetual contracts on Aug. 25, giving eligible traders leveraged exposure to Trump Media, Moderna and three semiconductor-focused exchange-traded funds.
The contracts began trading at five-minute intervals between 09:00 and 09:20 UTC. Binance listed SKUUUSDT, SKDDUSDT, RAMUSDT, DJTUSDT and MRNAUSDT with maximum leverage of 20x.
SKUUUSDT tracks the GraniteShares 2x Long SK Hynix Daily ETF. SKDDUSDT references the issuer's 2x Short SK Hynix Daily ETF. Both underlying funds trade on Nasdaq.
The long fund seeks twice the daily percentage change in SK Hynix's U.S.-listed depositary receipt. The short fund seeks twice the inverse daily return, according to GraniteShares' product details.
RAMUSDT references the Roundhill T-REX 2X Long DRAM Daily Target ETF, which trades on Cboe BZX. RAM targets twice the daily performance of the Roundhill Memory ETF, not a single semiconductor company.
DJTUSDT follows Trump Media & Technology Group shares. MRNAUSDT references Moderna. Both companies trade on Nasdaq under DJT and MRNA.
The five Binance products are perpetual derivatives priced and settled in USDT. Traders do not receive shares, voting rights, dividends or ownership interests in the referenced companies or ETFs.
Perpetual contracts have no expiry. Binance uses funding payments between long and short traders to keep contract prices aligned with reference markets.
Each contract has a minimum trade size of 0.01 units and a minimum notional value of 5 USDT. Funding fees settle every eight hours. The initial funding-rate cap is set at +2% and the floor at -2%.
The exchange said the normal rule allowing funding intervals to change from eight hours to one hour when rates reach their limits will not apply automatically. Binance will issue a separate announcement if it changes that schedule.
SKUU, SKDD and RAM are already leveraged ETFs designed around daily investment objectives. Applying 20x leverage through a perpetual contract creates an additional layer of exposure.
Daily leveraged funds can produce returns that differ greatly from a simple multiple of the underlying asset over longer periods. Compounding, volatility and daily resets can reduce returns even when the referenced asset moves in the expected direction.
Binance's leverage can further accelerate profits and losses. A relatively small adverse price movement may trigger liquidation if a trader lacks enough margin.
These risks are present outside U.S. stock-market hours. Binance offers the contracts continuously, while the referenced shares and ETFs trade during scheduled exchange sessions. Prices can therefore diverge when Nasdaq and Cboe BZX are closed.
The rollout follows a wider exchange push into 24/7 synthetic exposure to traditional assets. Bybit said its own TradFi perpetual range recently passed 200 products, including equities, ETFs, commodities and private companies.
The contracts were admitted to trading on the exchange RIE and to clearing and settlement through Binance RCH, according to the exchange's notice.
The company RIE is operated by Nest Exchange Limited, which the Abu Dhabi Global Market's Financial Services Regulatory Authority recognizes as an investment exchange for derivatives. Nest Clearing and Custody Limited operates Binance RCH as a recognized clearing house.
The regulatory structure does not make the products available everywhere. Binance cautioned that access depends on the user's location and applicable restrictions. The contracts reference U.S.-listed securities but are not direct Nasdaq or Cboe trades.
Binance may change leverage, margin, funding and other trading parameters under its exchange and clearing rules. No separate deadline or additional launch phase was announced.
There was no verified market movement in DJT, Moderna or the three ETFs that could be attributed specifically to the Binance listings.
The MRNA stock page carries an Alpha score of 54, with a Mixed label reflecting the wide gap between its vaccine pipeline potential and the capital markets reality of a stock that has lost 80% of its value over two years. That gap does not close with the addition of a 20x perpetual contract.
Drafted by a large language model from the source reporting linked above, then screened by automated publishing checks. It is not read by a journalist before publication. Some articles cite our Alpha Score. Verify prices and figures against the original source. Educational coverage, not personalized advice.